Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eohilia Maintenance Study in EoE (ORBIT2)
NCT02736409Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in eosinophilic esophagitis (EoE), sponsored by Takeda. Started Apr 2016; status: completed.
02
Drugs
EPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02736409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736409.